https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

They develop a device that allows performing robotic surgery assisted by pelvic navigation

27 de September de 2019

Surgeons at the Marqués de Valdecilla University Hospital (HUMV) have developed, with the advice of the IDIVAL Innovation Support Unit that belongs to the ITEMAS Platform, an arc-shaped device that allows surgery performed in the pelvis at the same time that are operated, with robotic assistance, pathologies in the organs of this same part of […]

Read more →

Deliberately multidisciplinary why we need new visions for the usual problems

26 de September de 2019

Frequently in the Spanish hospitals, the personnel in charge of the patients who enter the hospital find difficulties at the time of discharge, which extend the stay and are not due to clinical complications but to family or social factors. Generally, the patients, already older and in need of help in their self-care, need to […]

Read more →

IDIVAL organizes a strategic mission to Brussels

24 de September de 2019

A group of IDIVAL researchers, technicians and managers has traveled to Brussels with the aim of increasing the visibility of IDIVAL research groups at European level. The visit is part of the actions of internationalization of research in the health sector of our Autonomous Community, and has served to identify key actors in European research […]

Read more →

Granting of a Health Research Fund FIS project to the Translational Hematopathology group

23 de September de 2019

Recently, an aid for the health research project PI19 / 00041 has been granted to Santiago Montes Moreno, Principal Investigator, head of the emerging IDIVAL group of Translational Hematopathology. The project, entitled “Liquid Biopsy for the molecular diagnosis of patients with aggressive B lymphoma included in a clinical trial”, is a multicenter effort whose objective […]

Read more →

The Minister of Health signs the application to renew the IDIVAL accreditation as a Health Research Institute

9 de September de 2019

The Minister of Health of the Government of Cantabria, Miguel Rodríguez, has visited the facilities of the Marqués de Valdecilla Research Institute (IDIVAL) to meet the research teams and the projects that are being carried out. During his visit, he was accompanied by the director of the center, Galo Peralta; the director of Public Health, […]

Read more →

IDIVAL researchers study surgical ergonomics in nasosinus endoscopic procedures

5 de September de 2019

The incidence of cervicobrachial disorders in otolaryngologists is high. In other surgical specialties, knowledge of this problem has prompted the creation of new equipment, improvements in the design and distribution of the operating room, as well as greater postural awareness. Given the strong physical and psychological demands of endoscopic sinus surgery (CENS) and the limited […]

Read more →

IDIVAL patents a multivalent vaccine against listeriosis tuberculosis and pneumonia

2 de September de 2019

After the last outbreak of listeriosis occurred in Spain, the bacterium Listeria monocytogenes, has established itself in Spain as one of the pathogens causing more virulent food infections. In general, immunocompromised individuals are those with a high risk of listeriosis, either due to natural immunosuppression such as pregnancy, newborns or the elderly, or due to […]

Read more →

Study the use of beta-lactam monotherapy in bacteremia caused by Pseudomonas aeruginosa

13 de August de 2019

IDIVAL researchers belonging to the group of Epidemiology and Pathogenic and Molecular Mechanisms of Infectious Diseases and Microbiology led by Dr. Carmen Fariñas, head of the Infectious Service of the Marqués de Valdecilla Hospital have participated in a study recently published in the journal Clinical Infectious Diseases. This is a multinational and multicenter study in […]

Read more →

Progress in the treatment of bladder cancer

12 de August de 2019

Cancer represents a major health problem. It is estimated that, in 2019, almost 280,000 people will be diagnosed with this disease in our country. These figures are higher than in previous years. The most common tumors in Spain are those of the colon, prostate, breast, lung and urinary bladder. As the number of new diagnoses […]

Read more →

Two new cases of lymphoma B lymphoplasmacytic IgA with mutation of MYD88L265P

7 de August de 2019

Recently, the description of two cases of IgA lymphoplasmacytic lymphoma B with MYD88L265P mutation has been published in the journal HISTOPATHOLOGY (FI 3,294, JCR). In this work, in which medical researchers from the IDIVAL Emerging Group of Translational Hematopathology and doctors from the Pathology and Hematology Department of the HUMV have participated, two extremely unusual […]

Read more →